Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Peptide adcomm Day 2: Emideltide fails to make grade in vote
The first peptide to go up against an adcomm vote Friday did not fare as well as those assessed on Day 1 of the meeting.
Fraiser Kansteiner
Jul 24, 2026 2:00pm
Ipsen's liver disease drug Bylvay fails biliary atresia trial
Jul 24, 2026 11:00am
Operating at the speed of science: The new medical affairs playbook
Brought to you by
ZS
The Oral GLP-1 Tracker: Obesity prescriptions jump
Jul 24, 2026 11:00am
Access: A key driver of non-opioid pain management adoption
Brought to you by
Pacira BioSciences, Inc.
Amgen submits analyses to FDA in bid for Tavneos hearing
Jul 24, 2026 10:50am
